Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04557956 |
| Title | Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | Recruiting | Atlanta | Georgia | 30322 | United States | Details |
| Northwestern University | Recruiting | Chicago | Illinois | 60611 | United States | Details |
| Siteman Cancer Center at West County Hospital | Recruiting | Creve Coeur | Missouri | 63141 | United States | Details |
| Washington University School of Medicine | Recruiting | Saint Louis | Missouri | 63110 | United States | Details |
| University of Pittsburgh Cancer Institute (UPCI) | Recruiting | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| Huntsman Cancer Institute/University of Utah | Recruiting | Salt Lake City | Utah | 84112 | United States | Details |
| University of Wisconsin Carbone Cancer Center | Recruiting | Madison | Wisconsin | 53792 | United States | Details |